Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT
Background: In a previous trial we reported that the neuroprotective, anti-inflammatory antibiotic minocycline lessened the negative symptoms of schizophrenia compared with placebo over 1 year. The BeneMin study aimed to replicate this benefit and to determine whether or not there was associated pre...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2019-08-01
|
Series: | Efficacy and Mechanism Evaluation |
Subjects: | |
Online Access: | https://doi.org/10.3310/eme06070 |